218 related articles for article (PubMed ID: 10687328)
1. Judging the effectiveness of analgesia for children and adolescents during vaso-occlusive events of sickle cell disease.
Beyer JE
J Pain Symptom Manage; 2000 Jan; 19(1):63-72. PubMed ID: 10687328
[TBL] [Abstract][Full Text] [Related]
2. Improving the Management of Vaso-Occlusive Episodes in the Pediatric Emergency Department.
Kavanagh PL; Sprinz PG; Wolfgang TL; Killius K; Champigny M; Sobota A; Dorfman D; Barry K; Miner R; Moses JM
Pediatrics; 2015 Oct; 136(4):e1016-25. PubMed ID: 26391933
[TBL] [Abstract][Full Text] [Related]
3. Low-Dose Ketamine Infusion for Adjunct Management during Vaso-occlusive Episodes in Adults with Sickle Cell Disease: A Case Series.
Palm N; Floroff C; Hassig TB; Boylan A; Kanter J
J Pain Palliat Care Pharmacother; 2018 Mar; 32(1):20-26. PubMed ID: 29791238
[TBL] [Abstract][Full Text] [Related]
4. Tramadol infusion for the pain management in sickle cell disease: a case report.
Erhan E; Inal MT; Aydinok Y; Balkan C; Yegul I
Paediatr Anaesth; 2007 Jan; 17(1):84-6. PubMed ID: 17184440
[TBL] [Abstract][Full Text] [Related]
5. Opioid selection during sickle cell pain crisis and its impact on the development of acute chest syndrome.
Buchanan ID; Woodward M; Reed GW
Pediatr Blood Cancer; 2005 Oct; 45(5):716-24. PubMed ID: 15926170
[TBL] [Abstract][Full Text] [Related]
6. Patient-controlled analgesia versus continuous infusion of morphine during vaso-occlusive crisis in sickle cell disease, a randomized controlled trial.
van Beers EJ; van Tuijn CF; Nieuwkerk PT; Friederich PW; Vranken JH; Biemond BJ
Am J Hematol; 2007 Nov; 82(11):955-60. PubMed ID: 17617790
[TBL] [Abstract][Full Text] [Related]
7. Pain management in children with sickle cell disease.
Stinson J; Naser B
Paediatr Drugs; 2003; 5(4):229-41. PubMed ID: 12662119
[TBL] [Abstract][Full Text] [Related]
8. Management of vaso-occlusive episodes in the day hospital decreases admissions in children with sickle cell disease.
Karkoska K; Appiah-Kubi A; Rocker J; Stoffels G; Aygun B
Br J Haematol; 2019 Sep; 186(6):855-860. PubMed ID: 31148158
[TBL] [Abstract][Full Text] [Related]
9. Epidural analgesia in the management of severe vaso-occlusive sickle cell crisis.
Yaster M; Tobin JR; Billett C; Casella JF; Dover G
Pediatrics; 1994 Feb; 93(2):310-5. PubMed ID: 8121746
[TBL] [Abstract][Full Text] [Related]
10. Quantification of analgesic use in children with sickle cell disease.
Jacob E; Miaskowski C; Savedra M; Beyer JE; Treadwell M; Styles L
Clin J Pain; 2007 Jan; 23(1):8-14. PubMed ID: 17277639
[TBL] [Abstract][Full Text] [Related]
11. Fentanyl Buccal Tablet: A New Breakthrough Pain Medication in Early Management of Severe Vaso-Occlusive Crisis in Sickle Cell Disease.
De Franceschi L; Mura P; Schweiger V; Vencato E; Quaglia FM; Delmonte L; Evangelista M; Polati E; Olivieri O; Finco G
Pain Pract; 2016 Jul; 16(6):680-7. PubMed ID: 26009799
[TBL] [Abstract][Full Text] [Related]
12. Patient Controlled Analgesia for Vaso-Occlusive Episodes in Children: A Retrospective Study.
Donado C; Harris EM; Heeney MM; Solodiuk JC; Greco CD; Archer NM
J Pain Symptom Manage; 2023 May; 65(5):e409-e415. PubMed ID: 36641004
[TBL] [Abstract][Full Text] [Related]
13. Ketamine use for management of vaso-occlusive pain in pediatric sickle cell disease.
Harris EM; Vilk E; Donado C; Williams A; Heeney MM; Solodiuk J; Greco C; Archer NM
Pediatr Blood Cancer; 2023 May; 70(5):e30254. PubMed ID: 36861789
[TBL] [Abstract][Full Text] [Related]
14. Nurses' Attitudes Concerning Analgesia Administration for Pediatric Patients with Sickle Cell Disease in Jordan: A Cross-Sectional Study.
Abdel Razeq NM; Ali RA; Aqel A; Pack-Mabien AV; Sabbah EA; Qadiri IA; Aldasoqi KY
Pain Manag Nurs; 2024 Feb; 25(1):e29-e36. PubMed ID: 37648575
[TBL] [Abstract][Full Text] [Related]
15. Normal saline bolus use in pediatric emergency departments is associated with poorer pain control in children with sickle cell anemia and vaso-occlusive pain.
Carden MA; Brousseau DC; Ahmad FA; Bennett J; Bhatt S; Bogie A; Brown K; Casper TC; Chapman LL; Chumpitazi CE; Cohen D; Dampier C; Ellison AM; Grasemann H; Hickey RW; Hsu LL; Leibovich S; Powell E; Richards R; Sarnaik S; Weiner DL; Morris CR;
Am J Hematol; 2019 Jun; 94(6):689-696. PubMed ID: 30916794
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and analgesic effects of methadone in children and adults with sickle cell disease.
Horst J; Frei-Jones M; Deych E; Shannon W; Kharasch ED
Pediatr Blood Cancer; 2016 Dec; 63(12):2123-2130. PubMed ID: 27572136
[TBL] [Abstract][Full Text] [Related]
17. How French paediatric emergency departments manage painful vaso-occlusive episodes in sickle cell disease patients.
Galeotti C; Courtois E; Carbajal R
Acta Paediatr; 2014 Dec; 103(12):e548-54. PubMed ID: 25130719
[TBL] [Abstract][Full Text] [Related]
18. Intravenous magnesium sulfate for vaso-occlusive episodes in sickle cell disease.
Goldman RD; Mounstephen W; Kirby-Allen M; Friedman JN
Pediatrics; 2013 Dec; 132(6):e1634-41. PubMed ID: 24276838
[TBL] [Abstract][Full Text] [Related]
19. A randomized controlled trial comparing two vaso-occlusive episode (VOE) protocols in sickle cell disease (SCD).
Tanabe P; Silva S; Bosworth HB; Crawford R; Paice JA; Richardson LD; Miller CN; Glassberg J
Am J Hematol; 2018 Feb; 93(2):159-168. PubMed ID: 29047145
[TBL] [Abstract][Full Text] [Related]
20. Sickle Cell Disease Treatment with Arginine Therapy (STArT): study protocol for a phase 3 randomized controlled trial.
Rees CA; Brousseau DC; Cohen DM; Villella A; Dampier C; Brown K; Campbell A; Chumpitazi CE; Airewele G; Chang T; Denton C; Ellison A; Thompson A; Ahmad F; Bakshi N; Coleman KD; Leibovich S; Leake D; Hatabah D; Wilkinson H; Robinson M; Casper TC; Vichinsky E; Morris CR;
Trials; 2023 Aug; 24(1):538. PubMed ID: 37587492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
